UFP Technologies
| Primary URL | Location | Industry | ufpt[.]com |
Country
United States of America
|
Manufacturing
|
|---|
Profile
UFP Technologies is a medical device maker headquartered in Massachusetts, United States. The company designs, manufactures, and distributes a range of medical devices for healthcare providers. Its products are intended to support clinical procedures and patient care in various medical settings. UFP Technologies serves customers primarily within the United States healthcare market.
The organization’s headquarters location indicates a domestic footprint within the United States. No explicit figures regarding employee count, annual revenue, or global facilities are provided in the source material. The company’s operational base in Massachusetts situates it within a region known for a concentration of medical technology firms. This geographic context may facilitate access to skilled labor and industry networks.
As a medical device manufacturer, UFP Technologies operates within a highly regulated sector subject to oversight by agencies such as the U.S. Food and Drug Administration. Its distinguishing attribute lies in its focus on producing devices that must meet stringent safety and efficacy standards before market release. The company’s competencies likely include expertise in biomedical engineering, materials science, and quality management systems. These capabilities enable it to bring products that address specific clinical needs while maintaining compliance with regulatory requirements.
In February 2026, UFP Technologies disclosed a cybersecurity incident in which attackers infiltrated its IT systems, exfiltrated files, and destroyed data in a ransomware‑style attack. The intrusion disrupted systems used for billing and customer delivery labels, causing short‑term shipment delays while the firm assessed potential exposure of personally identifiable information. The company stated that the attack did not have a material impact on its financial condition and expects most direct response costs to be reimbursed by insurance. It is evaluating any additional regulatory filings required, anticipates restoring its primary information systems shortly, and believes it can recover any temporary operational setback.